New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

GNOMvsBBPETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF - USD

This fund is part of
BioTech & Genomics
-0.12%
Full GNOM fund page
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-0.38%
Full BBP fund page

Global X Genomics & Biotechnology ETF - USD (GNOM) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.79% for BBP. GNOM is down -0.99% year-to-date (YTD) with -$2M in YTD flows. BBP performs better with 6.54% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of GNOM and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs BBP performance and flow charts

Performance

-2.00.02.04.06.0%Feb 10Feb 18Feb 25Mar 4Mar 11

Cumulative Flows

0 M1 M2 M3 M4 MFeb 10Feb 18Feb 25Mar 4Mar 11

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
BBP
-2.35%+3.49%
-3.29%+9.58%
-0.99%+6.54%
+29.80%+42.80%
-6.02%+83.49%
-51.80%+60.18%
Flows
GNOM
BBP
-+$4M
-$4M+$16M
-$2M+$4M
-$19M+$19M
-$115M+$19M
+$11M+$9M
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
BBP
+23.45%+24.65%
+30.08%+25.47%
+28.53%+23.56%
+33.47%+26.14%
Max drawdown
GNOM
BBP
-10.89%-7.42%
-22.14%-17.97%
-46.50%-25.54%
-72.17%-38.24%
Max drawdown duration
GNOM
BBP
48d32d
113d106d
1031d292d
1714d915d
Trading data

Create an account to view trading data

Join for free
GNOM
BBP
Last sale
3/12/2026 at 1:30 PM
$43.93
$81.68
Previous close
03/11/2026
$45.00
$84.32
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
GNOM
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
GNOM
BBP
Last price
$43.93
$81.68
1D performance
-2.38%
-3.13%
AuM$49.36 M$50.98 M
E/R0.5%0.79%
Characteristics
GNOM
BBP
Management strategyPassivePassive
ProviderGlobal XVIRTUS Investment Partners
BenchmarkSolactive Genomics IndexLifeSci Biotechnology Products Index
N° of holdings4658
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

GNOM
USA
87.04%
Other
12.96%
BBP
USA
90.82%
Other
9.18%

Sectors

GNOM
Health Care
87.95%
Other
12.05%
BBP
Health Care
88.88%
Other
11.12%
Advertisement

Diversification

GNOM

Total weight of top 15 holdings out of 15

63.95%
BBP

Total weight of top 15 holdings out of 15

30.11%

Top 15 holdings

Data as of January 31, 2026
GNOM
MODERNA INC
6.79%
ARROWHEAD PHARMACEUTICALS INC
6.14%
US74006W2070
5.75%
ILLUMINA
5.64%
GUARDANT HEALTH INC
5.47%
NATERA
4.30%
VERTEX PHARMACEUTICALS
4.08%
BIONTECH SE ADR
4.04%
BIOMARIN PHARMACEUTICAL
3.93%
AVIDITY BIOSCIENCES
3.73%
BIO-TECHNE CORP
3.69%
CRISPR THERAPEUTICS
3.05%
ALNYLAM PHARMACEUTICALS
2.58%
VERACYTE INC/D
2.50%
BRISTOL-MYERS SQUIBB
2.28%
BBP
DAY ONE BIOPHARMACEUTICALS
2.39%
DYNAVAX TECHNOLOGIES
2.39%
AMICUS THERAPEUTICS
2.25%
IOVANCE BIOTHERAPEUTICS INC
2.18%
ARDELYX
2.09%
AXSOME THERA CMN STK
2.07%
BIONTECH SE ADR
2.07%
GILEAD SCIENCES
1.90%
KRYSTAL BIOTECH INC
1.89%
HALOZYME THERAPEUTICS
1.86%
US52635N1037
1.85%
AMGEN-T
1.83%
THERAVANCE BIOPHARMA
1.80%
INCYTE
1.78%
EXELIXIS
1.77%
Frequently asked questions about GNOM and BBP

How have the GNOM and BBP ETFs performed in 2026?

As of March 11, 2026, GNOM is down -0.99% year-to-date (YTD), while BBP has returned 6.54%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or BBP?

Year-to-date, the GNOM ETF saw -$2M in flows, compared to +$4M for BBP.

Which ETF is more volatile: GNOM or BBP?

Over the past year, GNOM had a volatility of 30.08%, while BBP experienced 25.47%.

Which ETF is bigger: GNOM or BBP?

As of March 11, 2026, GNOM holds $49.36 M in assets under management (AUM), while BBP manages $50.98 M.

What sectors do the GNOM and BBP ETFs invest in?

GNOM leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the GNOM ETF and BBP ETF?

GNOM top holdings include MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. BBP holds in its top three: DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS.

Which ETF is more diversified: GNOM or BBP?

GNOM holds 48 securities with 63.95% of its assets in the top 15. BBP has 63 securities and a top 15 weight of 30.11%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast